Skip Navigation

Medical Outcomes Study HIV

The Medical Outcomes Study HIV Health Survey

The Medical Outcomes Study HIV Health Survey (MOS-HIV) is a brief, comprehensive health status measure that has been used extensively in studies of human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS).  Developed in 1987 at the Johns Hopkins University, the MOS-HIV was one of the first disease-targeted measures available for this population and is widely used in clinical trials and other research and evaluation studies.  There is extensive evidence for the reliability, validity and usefulness of the MOS-HIV as a measure of patient-experienced outcome in HIV clinical trials.The MOS-HIV is available in 19 languages and has been included as a secondary outcome measure in numerous clinical trials for all stages of disease.

For more information about the licensing process and how to get access to the instrument and its translations, please consult the MOS HIV pages on our PROQOLID website.